Breaking Down Jazz Pharmaceuticals: 15 Analysts Share Their Views

Benzinga ·  Apr 10 10:01

Providing a diverse range of perspectives from bullish to bearish, 15 analysts have published ratings on Jazz Pharmaceuticals (NASDAQ:JAZZ) in the last three months.

The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.

BullishSomewhat BullishIndifferentSomewhat BearishBearish
Total Ratings59100
Last 30D01000
1M Ago43000
2M Ago14100
3M Ago01000

Analysts have recently evaluated Jazz Pharmaceuticals and provided 12-month price targets. The average target is $196.6, accompanied by a high estimate of $235.00 and a low estimate of $131.00. A decline of 0.87% from the prior average price target is evident in the current average.

price target chart

Interpreting Analyst Ratings: A Closer Look

The perception of Jazz Pharmaceuticals by financial...

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment